Skip to main content
A body of the European Union
Dark Theme
Search
Enter your keywords
Apply
Menu
Global challenges
About our communities
Added Value Manufacturing
Climate Change
Cultural & Creative Sectors & Industries
Digitalisation
Future of Food
Health Innovation
Raw Materials
Sustainable Energy
Urban Mobility
Activities
EIT Community Activities
Entrepreneurial Education
Innovation Driven Research
Business Creation
Regional Innovation Scheme
Knowledge Centre
EIT Awards
Opportunities
Current Opportunities
Call for EIT Communities
EIT Water
EIT Culture & Creativity
FAQs
Vacancies
Procurement
Open Calls
Other Calls and Notices
Newsroom
News
Events
Past events
Press
Newsletter
About Us
EIT at a glance
Success stories
EIT Ecosystem Map
EIT Governance
Meet the Governing Board
EIT Director
EIT Management Team
Public Meetings Record
EIT Alumni
Meet the Alumni Board
Activities
Stakeholders and Partners
EU institutions
National Authorities
Member State Representatives Group
Representatives and Substitutes
Documents
Legal framework
Data protection
Conflicts of Interest
Complaints
Public Access to Documents
Library
Get in Touch
FAQ
Back
Home
oncolytic viro-immuno therapy
Disruptive Innovations: EIT Health and highly innovative cancer treatments
Life Sciences & Health Hub Marconistraat, Rotterdam, 16 3029 AK
14/12/2017
10.30 - CET
14/11/2017
12.30 - CET
Health
Share this page
Twitter
Facebook
LinkedIn
Email
Share this page
